Decoy Therapeutics Inc. Other Comprehensive Income (Loss), Net of Tax
Decoy Therapeutics Inc. (DCOY) reported Other Comprehensive Income (Loss), Net of Tax of $23.04 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-08.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2017-03-08
- Decoy Therapeutics Inc. other comprehensive income (loss), net of tax for fiscal 2016 was $23.04K.
- Decoy Therapeutics Inc. other comprehensive income (loss), net of tax for fiscal 2015 was -$24.65K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 10 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|
| 2016-12-31 | $23.04K 10-K · filed 2017-03-08 | |
| 2015-12-31 | -$24.65K 10-K · filed 2017-03-08 | |
| 2014-12-31 | $0.00 10-K · filed 2017-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |